Literature DB >> 16997560

A metabolically stable tight-binding transition-state inhibitor of glyoxalase-I.

Swati S More1, Robert Vince.   

Abstract

The design, synthesis, and enzyme kinetics evaluation of a transition-state inhibitor of glyoxalase-I is described. The union of the hydroxamic acid zinc-chelator with a urea isostere for the glu-cys amide bond led to a glutathione analog which retained inhibitory potency toward glyoxalase-I while possessing resistance toward gamma-glutamyltranspeptidase mediated breakdown. This compound is viewed as a potential lead for the development of second-generation glyoxalase-I inhibitors wherein, the problems pertaining to metabolism and selectivity are overcome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16997560     DOI: 10.1016/j.bmcl.2006.08.121

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

Review 1.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

2.  Interactions between human glutamate carboxypeptidase II and urea-based inhibitors: structural characterization.

Authors:  Cyril Barinka; Youngjoo Byun; Crystal L Dusich; Sangeeta R Banerjee; Ying Chen; Mark Castanares; Alan P Kozikowski; Ronnie C Mease; Martin G Pomper; Jacek Lubkowski
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

Review 3.  Prodrug approach for increasing cellular glutathione levels.

Authors:  Ivana Cacciatore; Catia Cornacchia; Francesco Pinnen; Adriano Mollica; Antonio Di Stefano
Journal:  Molecules       Date:  2010-03-03       Impact factor: 4.411

4.  Multi-Armed 1,2,3-Selenadiazole and 1,2,3-Thiadiazole Benzene Derivatives as Novel Glyoxalase-I Inhibitors.

Authors:  Qosay A Al-Balas; Mousa L Al-Smadi; Mohammad A Hassan; Ghazi A Al Jabal; Ammar M Almaaytah; Karem H Alzoubi
Journal:  Molecules       Date:  2019-09-04       Impact factor: 4.411

5.  Novel glyoxalase-I inhibitors possessing a "zinc-binding feature" as potential anticancer agents.

Authors:  Qosay A Al-Balas; Mohammad A Hassan; Nizar A Al-Shar'i; Nizar M Mhaidat; Ammar M Almaaytah; Fatima M Al-Mahasneh; Israa H Isawi
Journal:  Drug Des Devel Ther       Date:  2016-08-17       Impact factor: 4.162

6.  Generation of the first structure-based pharmacophore model containing a selective "zinc binding group" feature to identify potential glyoxalase-1 inhibitors.

Authors:  Qosay Al-Balas; Mohammad Hassan; Buthina Al-Oudat; Hassan Alzoubi; Nizar Mhaidat; Ammar Almaaytah
Journal:  Molecules       Date:  2012-11-22       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.